Back
Exelixis Vs. Inovio Pharmaceuticals Industry Stock Comparison
Buy
84
EXEL
Exelixis
Last Price:
36.48
Seasonality Move:
13.57%
Sell
28
INO
Inovio Pharmaceuticals
Last Price:
4.33
Seasonality Move:
16.95%
Buy
84
Exelixis (EXEL)
is a Buy
Is Exelixis a Buy, Sell or Hold?
- The current Exelixis [EXEL] share price is $36.46. The Score for EXEL is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- EXEL is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
28
Inovio Pharmaceuticals (INO)
is a Sell
Is Inovio Pharmaceuticals a Buy, Sell or Hold?
- The current Inovio Pharmaceuticals [INO] share price is $4.32. The Score for INO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- INO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EXEL Stock Price Chart
INO Stock Price Chart
What is Inovio Pharmaceuticals's stock price today?
-
The Inovio Pharmaceuticals share price today is $4.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INO is experiencing buying pressure, which is a positive indicator for future bullish movement.
EXEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 72.17 | Buy |
| Chaikin Money Flow: | -362544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.89 - 36.71) | Buy |
| Bollinger Bands (100): | (23.51 - 32.03) | Buy |
INO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 36.02 | Sell |
| Chaikin Money Flow: | 123972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.22 - 5.56) | Sell |
| Bollinger Bands (100): | (4.83 - 8.97) | Sell |
EXEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.59 | Buy |
| 20-day SMA: | 35.34 | Buy |
| 50-day SMA: | 30.58 | Buy |
| 200-day SMA: | 25 | Buy |
| 8-day EMA: | 35.8 | Buy |
| 20-day EMA: | 34.6 | Buy |
| 50-day EMA: | 31.68 | Buy |
| 200-day EMA: | 26.26 | Buy |
INO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.1 | Buy |
| 20-day SMA: | 4.73 | Sell |
| 50-day SMA: | 5.29 | Sell |
| 200-day SMA: | 8.58 | Sell |
| 8-day EMA: | 4.23 | Buy |
| 20-day EMA: | 4.6 | Sell |
| 50-day EMA: | 5.37 | Sell |
| 200-day EMA: | 7.48 | Sell |
Exelixis Earnings Growth & EXEL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and an increase next year of $0.01 per share.
Inovio Pharmaceuticals Earnings Growth & INO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.88 per share, and an increase next year of $0.66 per share.
Exelixis Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Inovio Pharmaceuticals Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||